Advertisement

Topics

Pembrolizumab as First-Line Treatment for Non–Small-Cell Lung Cancer?

20:00 EDT 17 Oct 2016 | NEJM

Survival data from a randomized comparison with platinum-based chemotherapy suggest yes for some patients.

Original Article: Pembrolizumab as First-Line Treatment for Non–Small-Cell Lung Cancer?

NEXT ARTICLE

More From BioPortfolio on "Pembrolizumab as First-Line Treatment for Non–Small-Cell Lung Cancer?"

Quick Search
Advertisement